Novel Ga-68 PET bone-targeting agent tested in vivo, ex vivo and in metastatic bone cancer patients June 20, 2014 No Comments
Radiosynthesis and microPET evaluation of F-18 CRF1 receptor PET tracer presented June 18, 2014 No Comments
FDA approves Gadavist as a contrast agent for the evaluation of breast cancer June 13, 2014 No Comments
RSS